Ubs Group Ag Pro Mis Neurosciences Inc. Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Ubs Group Ag holds 250 shares of PMN stock, worth $447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 5,926
95.78%
Holding current value
$447
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PMN
# of Institutions
17Shares Held
3.38MCall Options Held
0Put Options Held
0-
Sphera Funds Management Ltd. Tel Aviv, L31.83MShares$3.28 Million0.55% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.06MShares$1.9 Million1.78% of portfolio
-
Affinity Asset Advisors, LLC New York, NY266KShares$476,0640.07% of portfolio
-
Northeast Financial Consultants Inc Westport, CT100KShares$179,0000.01% of portfolio
-
Bank Of Montreal Toronto, A630.4KShares$54,3550.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...